| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| 288 SHARES VALEANT PHARMACEUTICALS | 2003-11 | PURCHASE | 2011-12 | 12,767 | 3,819 | |||||
| EXCESS FUNDS FROM SALE CUSIP NUMBER 26824A10 | 2011-10 | 2011-10 | 196 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| 288 SHARES VALEANT PHARMACEUTICALS | 2003-11 | PURCHASE | 2011-12 | 12,767 | 3,819 | |||||
| EXCESS FUNDS FROM SALE CUSIP NUMBER 26824A10 | 2011-10 | 2011-10 | 196 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FRAZIER & FRAZIER-TAX RTN PREP | 600 | 600 | ||
| FRAZIER & FRAZIER-FINAL TAX RTN | 1,000 | 1,000 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FRAZIER & FRAZIER-TAX RTN PREP | 600 | 600 | ||
| FRAZIER & FRAZIER-FINAL TAX RTN | 1,000 | 1,000 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ML EMA ANNUAL FEE | 150 | 150 | 150 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| 2010 FORM 990 TAXES PD 5-16-11 | 57 | 57 |